The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Immunologic Mechanisms in the Pathogenesis of Rheumatoid Arthritis
Abstract
Although much is known about the etiology and pathogenesis of rheumatoid arthritis (RA), our understanding of the immune pathways remains incomplete. The observed clinical and pathologic manifestations result from activation of several interrelated immune pathways. Current concepts of RA pathogenesis, supported by animal models, laboratory studies, and clinical observation, have reestablished and revised some of the original views. Early proposals emphasized the importance of autoantibodies and immune complexes in the initiation of RA, suggested a role for T cells in the inflammatory response characteristic of RA, and based disease perpetuation on an imbalance in the cytokine networks. We now recognize that each of these interrelated mechanisms significantly contributes to RA pathogenesis, including T cells that can help initiate and perpetuate the disease. This article reviews the major components and immune pathways involved in RA and briefly discusses the animal models that contribute to our understanding. Although a unified theory of RA pathogenesis may not be possible at this time, a paradigm is presented that considers the immune pathways that contribute to disease progression and joint destruction. These pathways may have important implications for treatment, because their modulation by biologic response modifiers (BRMs) directed toward specific targets provides benefits to patients with RA. BRMs are a new class of therapeutic agents derived from biologically active molecules and designed to modulate specific immune or inflammatory pathways. Although currently approved BRMs still have limitations, choosing an appropriate target, possibly early rather than late in the immune response, might result in new and improved therapies for RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease
Matsumoto, I., Maccioni, M., Lee, D. M., Maurice, M., Simmons, B., Brenner, M., Mathis, D., & Benoist, C. (2002) · Nature Immunology · doi:10.1038/ni772 · Cited by 329
Cited by
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Immunity to Citrullinated Proteins in Rheumatoid Arthritis
Klareskog, L., Rönnelid, J., Lundberg, K., Padyukov, L., & Alfredsson, L. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090244 · Cited by 463
Neutrophil apoptosis and the resolution of infection
Kennedy, A. D., & DeLeo, F. R. (2009) · Immunologic Research · doi:10.1007/s12026-008-8049-6 · Cited by 400
The role of the JAK/STAT signal pathway in rheumatoid arthritis
Malemud, C. J. (2018) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x18776224 · Cited by 302
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis
Bang, H., Egerer, K., Gauliard, A., Lüthke, K., Rudolph, P. E., Fredenhagen, G., Berg, W., Feist, E., & Burmester, G. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22817 · Cited by 293
Metadata
- Authors
- Firestein, G. S.
- Venue
- JCR: Journal of Clinical Rheumatology
- Published
- 2005-06
- Volume
- 11
- Issue
- 3
- Pages
- S39-S44
- ISSN
- 1076-1608 (ISSN-L)
- OpenAlex
- W2044601575
- Cited by
- 243
- References
- 1
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunologic Mechanisms in the Pathogenesis of Rheumatoid Arthritis. https://app.cochat.ai/papers/10.1097/01.rhu.0000166673.34461.33
- The paper
- Firestein, G. S. (2005). Immunologic Mechanisms in the Pathogenesis of Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology. https://doi.org/10.1097/01.rhu.0000166673.34461.33
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.